SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Wednesday 4 November 2026
News from the 24 hours to Wednesday morning, 4 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on an upcoming trading update and a recent cartilage implant launch, alongside a Breakingviews column arguing the company needs bolder restructuring. The critical column outweighs the neutral previews, so the lean is slightly negative.
What drove it
- upcoming trading update
- turnaround criticism
- cartilage implant launch
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Thu 29 Oct | −5.8 | 1 |
| Fri 30 Oct | −4.7 | 1 |
| Sun 1 Nov | 0.0 | 1 |
| Tue 3 Nov | +5.0 | 2 |
| Wed 4 Nov | −1.7 | 4 |
3 stories · 4 headlines · strongest first
Pharma and healthcare on 4 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew Q3 trading report and 4 November call +1.32 headlines today · 5 in all, since 9 October · Pieces preview the trading update due tomorrow and ask about its sector position. | ||
| +1.7 | Previews upcoming trading update following a new cartilage product launch. | |
| +0.8 | Commentary on its competitive standing; speculative and fairly neutral. | |
| Breakingviews on Smith & Nephew fix −5.81 headline today · Breakingviews says the remedy for Smith & Nephew calls for more extensive surgery. | ||
| −5.8 | Opinion column says its turnaround needs more drastic action. | |
| Smith & Nephew technical signals 0.01 headline today · A piece covers technical signals for the shares. | ||
| 0.0 | Technical trading signals article on its US-listed shares; purely market-chart commentary. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.